UniProtKB/Swiss-Prot P24158: Variant p.Thr136Ser

Myeloblastin
Gene: PRTN3
Feedback?

Variant information Variant position:

136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Threonine (T) to Serine (S) at position 136 (T136S, p.Thr136Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and polar (T) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs1042282 [ dbSNP | Ensembl ]

Sequence information Variant position:

136 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

256 The length of the canonical sequence.
Location on the sequence:

LNDVLLIQLSSPANLSASVA T VQLPQQDQPVPHGTQCLAMG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LNDVLLIQLSSPANLSASVATVQLPQQDQPVPHGTQCLAMG

Mouse                         LNDVLLLQLNRTASLGKEVAVASLPQQDQTLSQGTQCLAMG

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	28 – 248	Myeloblastin
Domain	28 – 248	Peptidase S1
Active site	118 – 118	Charge relay system
Glycosylation	129 – 129	N-linked (GlcNAc...) asparagine

Literature citations
Wegener autoantigen and myeloblastin are encoded by a single mRNA.
Labbaye C.; Musette P.; Cayre Y.E.;
Proc. Natl. Acad. Sci. U.S.A. 88:9253-9256(1991)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS ILE-119; THR-135 AND SER-136; Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen.
Sturrock A.B.; Franklin K.F.; Rao G.; Marshall B.C.; Rebentisch M.B.; Lemons R.S.; Hoidal J.R.;
J. Biol. Chem. 267:21193-21199(1992)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-254; VARIANTS THR-135 AND SER-136; Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells.
Bories D.; Raynal M.-C.; Solomon D.H.; Darzynkiewicz Z.; Cayre Y.E.;
Cell 59:959-968(1989)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 20-256; VARIANTS ILE-119; THR-135 AND SER-136; Wegener's autoantigen decoded.
Jenne D.E.; Tschopp J.; Luedemann J.; Utecht B.; Gross W.L.;
Nature 346:520-520(1990)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 20-256; PROTEIN SEQUENCE OF 28-48; VARIANTS ILE-119; THR-135 AND SER-136; IDENTITY OF WEGENER'S AUTOANTIGEN WITH PR-3;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.